INTRODUCTION
The adult mammalian pancreas is composed of exocrine and endocrine cells which appear to develop from a common precursor cell. Recently, a variety of transcription factors have been identified that function at different stages during pancreas development [1] [2] [3] [4] [5] [6] [7] . Pdx-1 (also termed IPF1, STF-1, IDX-1) is a homeodomain transcription factor that is expressed early (mouse embryonic day 8.5) during the development of the pancreas [8] [9] [10] . Mice with a targeted disruption of the Pdx-1 gene are born apancreatic [1, 2] , emphasizing the importance of Pdx-1 in pancreatic development. In the adult pancreas, Pdx-1 expression is restricted to the pancreatic β-cells residing in the islets of Langerhans [8, 11] . Pdx-1 has been proposed to regulate the expression of a variety of pancreatic endocrine cell genes, including insulin [8, [12] [13] [14] , somatostatin [9, 10] , the glucose transporter GLUT2 [15] , islet amyloid polypeptide [16] and glucokinase [17] through its ability to interact at A-T rich regions contained within the promoter of these genes. A recent study by Ahlgren et al. [18] has shown that selective disruption of Pdx-1 in pancreatic β-cells markedly alters β-cell phenotype by decreasing insulin, islet amyloid polypeptide and GLUT2 expression while increasing glucagon expression, thus providing evidence that Pdx-1 plays an essential role in maintenance of the β-cell phenotype.
Although Pdx-1 plays an important role in the maintenance of β-cell phenotype, the transcriptional mechanisms involved in Pdx-1 gene expression remain poorly understood. Sharma et al. [19] have shown that a rat Pdx-1 gene promoter fragment containing 6500 bp of 5h-flanking sequences was sufficient for targeting expression of a β-galactosidase (β-GAL) reporter gene to pancreatic β-cells and endocrine cells in the duodenum of transgenic mice. Similarly, Wu et al. [20] found that mouse Pdx-1 gene promoter sequences, including 4500 bp upstream of the transcription start site, were also sufficient for targeting reporter gene expression to these tissues. Although these promoter regions have not been completely characterized, HNF3β has been shown to bind and regulate both rat and mouse distal Pdx-1 promoter elements [20, 21] .
Within the rat proximal Pdx-1 promoter, Sharma et al. [19] have also defined a mutationally sensitive E-box element located between k107 and k102. This E-box motif is capable of binding in itro to the upstream stimulatory factor (USF). Based on this evidence, USF has been suggested to regulate Pdx-1 gene expression. USF proteins are members of the basic\helix-loophelix\leucine zipper family of transcription factors and were first identified for their role in regulating transcription of the adenovirus major late promoter [22] [23] [24] . Two forms of USF, USF1 and USF2, are encoded by separate genes [25] [26] [27] [28] . USF proteins primarily bind as USF1\USF2 heterodimers to specific sites with a CACGTG consensus sequence [22, 25, 27] . USF proteins are ubiquitously expressed and USF binding sites have been identified in a variety of cellular and viral genes (for examples see [29] [30] [31] [32] [33] [34] ). Nonetheless, other members of basic\helix-loop-helix\leucine zipper family of transcription factors such as Myc, Max, Myn, Mad, Mxi, TFE3, TFEB, MITF and SREBP (ADD-1) can also bind similar DNA elements as USF [35] [36] [37] [38] [39] [40] [41] [42] [43] , thus making it impossible to determine by mutational analysis which member of the family functionally regulates a particular gene in i o. Due to this major caveat, site-directed mutagenesis of DNA regulatory elements and in itro DNA binding do not constitute sufficient evidence to establish that USF functionally regulates Pdx-1 gene expression.
To address whether USF plays a functional role in the regulation of Pdx-1 gene expression, we have used a recombinant adenovirus engineered to overexpress a dominant-negative form of the USF2 protein. We demonstrate that overexpression of the dominant-negative USF, termed USF2∆B, reduced Pdx-1 gene promoter activity, Pdx-1 mRNA and protein levels. The reduction in Pdx-1 protein levels led to a commensurate reduction in Pdx-1 binding activity to the A3 element on the insulin promoter and a significant reduction in insulin mRNA levels. Overall, these results indicate that Pdx-1 gene transcription is functionally regulated by USF.
EXPERIMENTAL Materials
Cell culture materials, lipofectamine, random primer labelling kits, and enzymes were from Gibco-BRL (Gaithersburg, MD 
Cell culture
INS-1 cells were routinely cultured in CO # \air (1 : 19) at 37 mC in RPMI-1640 media containing 11.1 mM glucose and supplemented with 10 % fetal-bovine serum, 1 mM pyruvate, 10 mM Hepes, 50 µM 2-mercaptoethanol, 100 units penicillin\ml and 100 µg streptomycin\ml. In all experiments the RPMI-1640 medium contained the supplements described above. Cells were passaged weekly by trypsin\EDTA detachment. All studies were performed on INS-1 cells between passages 70 and 80.
Preparation of recombinant adenovirus encoding dominant negative USF2
A recombinant adenovirus containing the cDNA sequences encoding for USF2∆B was prepared according to the method of Becker et al. [44] . The recombinant adenovirus, AdCMV-USF2∆B, was prepared by insertion of the murine USF2∆B cDNA sequences [29] into the plasmid pACCMV.pL.pA adjacent to the CMV promoter. pACCMV.pL.pA containing the USF2∆B cDNA was then co-transfected with pJM17 plasmid into HEK-293 cells. The resultant recombinant virus was amplified in HEK-293 cells and titred by plaque assay [44] . INS-1 cells were untreated or were transduced with AdCMV-USF2∆B or with a control virus containing the β-GAL gene [each at 50 plaqueforming units (p.f.u.) per cell] for 1 h. The viral incubation media was then replaced with RPMI-1640 media.
Nuclear extracts and electrophoretic mobility-shift assays (EMSA)
INS-1 cells were plated at a density of 10i10' cells in a 100-mm dish 2 days before viral treatment. Cells were then mock transduced or transduced with AdCMV-βGAL or AdCMV-USF2∆B (50 p.f.u. per cell) and, 2 to 3 days after treatment, nuclear extracts were isolated as described previously [45] . Protein concentrations were determined by method of Lowry et al. [46] . Double-stranded oligodeoxynucleotide probes to the rat Pdx-1 E-box element (k118 GGCCCCAGGCTGAACCACGTGG-GGTGCC k95), human insulin gene A3 element (previously termed the CT2 motif ; k230 CCCCTGGTTAAGACTCT-AATGACCCGCTGG k201) and rat pyruvate kinase HNF-4 binding site (k146 TCCTGGACTCTGGCCCCCAGTGT k124) were labelled with [α$#P]dCTP by filling in overhanging 5h ends with the large fragment of DNA polymerase 1. Binding reactions (5-10 µg of protein per lane) and electrophoresis were performed as described previously by Olson et al. [45] . Supershift analysis for Pdx-1 binding activity was performed by the addition of 2 µl of anti-N-terminal XIHbox8 antibodies. This anti-Nterminal XIHbox8 antiserum was raised against amino acid residues 1-75 of the XIHbox8 protein, a region highly conserved within the Pdx-1 protein [12] . Previous studies have shown that the anti-N-terminal XIHbox8 antiserum specifically supershifts the Pdx-1 protein-DNA complex when HIT cell and INS-1 cell nuclear extracts are used [12, 45, 47] . Supershift analysis for USF was performed by the addition of 2 µl of anti-USF1 antibodies.
Western-blot analysis of nuclear proteins
Nuclear extracts (30 µg) were resolved by SDS\PAGE (10 % gel). Resolved proteins were then transferred to nitrocellulose membranes and Pdx-1, USF1 or USF2 immunoreactivity was detected using anti-N-terminal XIHbox8, anti-USF1 antibodies and anti-USF2 antibodies respectively. Immunoreactivity was visualized by chemiluminescence and bands were quantified by scanning densitometry and NIH image software.
RNA isolation and Northern-blot analysis
Cells were plated at a density of 5i10' cells per 60-mm dish in RPMI-1640 medium containing 11.1 mM glucose, and 2 days later the cells were mock transduced or transduced with 50 p.f.u. per cell AdCMV-βGAL or AdCMV-USF2∆B. Total RNA was extracted 2 to 3 days after infection and Northern blots were performed as described previously [45] . Briefly, 10-20 µg of total RNA was separated on a 1.5 % (w\v) agarose gel containing 6.7 % formaldehyde and transferred on to a Nytran nylon membrane. Blots were probed with cDNAs from human β-actin, Syrian hamster preproinsulin and rat Pdx-1, as described previously [45] . Northern blots were quantified using a phosphorimager.
Reporter genes studies
The plasmids Pdx-1[k6.5kb]LUC and Pdx-1[k190]LUC contain the LUC gene under transcriptional regulation by the rat Pdx-1 gene sequences k6500 to j68 and k190 to j78 respectively [19] . The plasmids Pdx-1[k6.5kbEm]LUC and Pdx-1[k190Em]LUC contain a mutated E-box motif (k118\k95) in the context of the 6500 or 190 bp Pdx-1 promoter respectively [19] . Construction of CMV4-USF2 and CMV4-USF2∆B expression vectors has been described previously by Kaytor et al. [34] .
For transfection of adenovirus-infected cells, INS-1 cells were subcultured at a density of 1.5i10' cells\well (diam. 3.5 cm) in RPMI-1640 medium 2 days before transduction. Cells were then mock transduced or transduced with 50 p.f.u. per cell AdCMV-βGAL or AdCMV-USF2∆B. Twenty-four hours later cells were transfected with 1 µg of reporter gene DNA for 4 h at 37 mC using 4 µl of Lipofectamine. The cells were harvested 24 h after transfection and LUC activity was assayed.
For all co-transfection experiments, INS-1 cells were subcultured at a density of 1.5i10' cells\well in RPMI-1640 medium 2 days before transfection. In experiments designed to test the ability of wild-type USF2 to reverse USF2∆B suppression of Pdx-1 gene promoter activity (see Figure 3 ), cells were transfected with 1 µg of Pdx-1[k190]LUC, 2 µg of CMV4-USF2∆B or 1 or 2 µg of CMV4-USF2 and 20 µl Lipofectin. All cells were transfected with equal amounts of DNA by use of a CMV4-expression plasmid containing no insert. For co-transfection experiments designed to examine the role of the Pdx-1 E box (see Table 2 ), INS-1 cells were transfected with 1 µg of reporter DNA, 2 µg of CMV4-USF2∆B and 16 µl of Lipofectamine. For these experiments, control cells were transfected with 1 µg of reporter DNA and 2 µg of CMV4-expression plasmid containing no insert. Cells were harvested 48 h after co-transfection and LUC activity assayed.
RESULTS

Dominant negative form of USF2 decreases USF binding activity in INS-1 cells
Recently, Sharma et al. [19] identified an E box located within the Pdx-1 gene (k107\k102) that, when mutated, strongly reduced promoter activity. Although this E box serves as a binding site for USF in itro, it has yet to be determined whether USF functionally regulates activity of the Pdx-1-gene promoter
Figure 1 Expression of USF and USF2∆B in AdCMV-USF2∆B treated INS-1 cells
Upper panel : schematic comparison of the structures of USF2 and USF2∆B. USF2∆B was generated from mouse USF2 [66] in cells. To determine whether USF may regulate the expression of the Pdx-1 gene, a dominant-negative form of USF2 (USF2∆B) was overexpressed in INS-1 cells using a recombinant adenovirus (AdCMV-USF2∆B). In the USF2∆B protein, the basic region of the USF DNA-binding domain was deleted and the nuclear localization, helix-loop-helix and leucine zipper domains remained intact (Figure 1, upper panel) . The USF2∆B protein retained the ability to dimerize with endogenous USF1 and USF2, but the heterodimer was unable to bind DNA [29] . The expression of USF2∆B was determined by Western-blot analysis of nuclear extracts derived from untreated, AdCMV-βGAL- The effectiveness of USF2∆B for disrupting binding of USF to the Pdx-1 gene E box (k107\k102) was determined by EMSA using a double-stranded oligodeoxynucleotide probe corresponding to the rat Pdx-1 gene sequences k118 to k95. Nuclear extracts derived from untreated and AdCMV-βGAL-treated INS-1 cells formed a DNA-protein complex with the Pdx-1 gene E box ( Figure 2, left panel ; lanes 2 and 3) . This E-box-binding complex could be supershifted by the addition of anti-USF1 antibodies ( Figure 2 , left panel ; lane 5). In nuclear extracts derived from AdCMV-USF2∆B-treated INS-1 cells, the E-box To confirm that USF2∆B suppressed promoter activity by directly interacting with USF, we examined the ability of wildtype USF2 to reverse USF2∆B inhibition of Pdx-1 promoter activity. For these studies, INS-1 cells were transiently transfected with a CMV4-USF2∆B expression vector. Transient transfection of INS-1 cells with 2 µg of CMV4-USF2∆B reduced the expression of Pdx-1[k190]LUC to 65p6.6 % (n l 5, P 0.004) of that observed for control cells (Figure 3) . The reduction in Pdx-1[k190]LUC expression in this experiment was not as large as that shown in Table 2 , most likely because of the less effective expression of USF2∆B resulting from the addition of CMV4 carrier DNA. Transfection of 2 µg of CMV4-USF2 completely reversed the dominant negative action of USF2∆B overexpression on the Pdx-1[k190]LUC reporter gene (Figure 3) . Regulation of Pdx-1 gene expression by upstream stimulatory factor To determine whether overexpression of USF2∆B decreased Pdx-1 gene promoter activity solely by interfering with USF binding to the E box located at k107\k102, constructs with a mutation of this E-box sequence were tested. Since previous studies by Sharma et al. [19] had demonstrated a role for the k107\k102 E box in Pdx-1 promoter activity in HIT-T15 cells, it was first necessary to test the effect of E-box mutations in INS-1 cells. As predicted, expression of Pdx-1[k6.5kbEm]LUC was reduced to 8.2p0.5 % (n l 3, P 0.002) of that observed for wild-type Pdx-1[k6.5kb]LUC (Table 2) . Similarly, expression of Pdx-1[k190Em]LUC was 15.0p1.4 % (n l 3, P 0.002) of that observed for wild-type Pdx-1[k190]LUC (Table 2 ). These results indicate that the E-box motif located at k107\k102 of the Pdx-1 gene promoter plays an important role in determining promoter activity in INS-1 cells, as previously reported for HIT-T15 cells [19] . These same constructs, containing E-box mutations, were tested in INS-1 cells co-transfected with a CMV4-USF2∆B expression vector. Co-transfection of wild-type Pdx-1 reporter genes, Pdx-1[k6.5kb]LUC or Pdx-1[k190]LUC with 2 µg of CMV4-USF2∆B reduced LUC expression to 39p5.9 % (n l 3, P 0.001) and 32p1.0 % (n l 3, P 0.003) of that observed in control cells respectively (Table 2) . Surprisingly, co-transfection of CMV4-USF2∆B also reduced expression of Pdx-1[k6.5kbEm]LUC and Pdx-1[k190Em]LUC to 52p3.1 % (n l 3, P 0.005) and 55p5.6 % (n l 3, P 0.01) of that observed in control cells respectively (Table 2 ). These results indicate that the ability of USF2∆B to reduce Pdx-1 gene promoter activity is, in part, mediated through the E-box sequence located at k107\k102, but that additional USF regulatory sites present within the Pdx-1 k190 bp promoter region may also contribute to its action.
Expression of USF2∆B diminishes Pdx-1 mRNA levels and protein levels
A significant reduction in Pdx-1 promoter activity by USF2∆B overexpression should reduce the endogenous levels of both Pdx-1 mRNA and protein. The effect of USF2∆B overexpression on Pdx-1 mRNA levels was measured by Northern-blot analysis. Pdx-1 mRNA levels were not significantly affected by treatment of INS-1 cells with AdCMV-βGAL compared with control cells (Figure 4 , left panel ; compare lane 1 with lane 2), indicating that viral transduction does not non-specifically alter Pdx-1 mRNA levels. In contrast, 48 h after AdCMV-USF2∆B infection Pdx-1 mRNA levels were reduced to 24p5.6 % (n l 3, P 0.005) of control cells ( Figure 4, left panel ; lane 3) , but 72 h after AdCMV-USF2∆B treatment, Pdx-1 mRNA levels were reduced to 45p2.6 % (n l 3, P 0.005) of control cells ( Figure 4 , left panel ; lane 4), suggesting some recovery of Pdx-1 gene expression. Importantly, overexpression of USF2∆B had no effect on β-actin mRNA levels (see Figure 6 ) indicating that the changes in Pdx-1 mRNA levels were not due to global changes in gene expression.
The effect of USF2∆B overexpression on Pdx-1 protein levels was measured by Western-blot analysis. As observed for Pdx-1 mRNA levels, there were no significant changes in Pdx-1 protein levels 48 h after INS-1 cells were treated with AdCMV-βGAL when compared with control cells (Figure 4 , right panel ; compare lane 1 with lane 2). AdCMV-USF2∆B treatment, however, reduced Pdx-1 protein levels to 14p0.5 % (n l 2) of control cells ( Figure 4 , right panel ; lane 3). These data demonstate that effects of USF2∆B on Pdx-1 promoter activity translate into marked reductions in Pdx-1 mRNA and protein levels.
Effect of USF2∆B on Pdx-1 binding to the insulin promoter and on insulin mRNA levels
Two A-T rich elements, termed the A1 and A3 elements, are highly conserved among all characterized mammalian insulin gene promoters [12, [50] [51] [52] . The predominant β-cell binding activity to the A1 and A3 elements is Pdx-1 [8] [9] [10] . Since overexpression of USF2∆B markedly reduced Pdx-1 mRNA and protein levels, one would predict a commensurate reduction in Pdx-1 binding activity to the insulin promoter A1 and A3 elements. To test this prediction, EMSAs were performed using a double-stranded oligodeoxynucleotide probe containing the human insulin gene A3 element (k230\k201). As observed for both Pdx-1 mRNA and protein levels, no significant differences in A3 element binding was observed in extracts from INS-1 cells treated with AdCMV-βGAL compared with control cells ( Figure  5, lane 2 versus lane 3) . However, extracts from AdCMV-USF2∆B treated cells reduced A3 binding activities to 44p4.5 % (n l 3, P 0.001) compared with control cells (Figure 5, lane 4) . To confirm that the A3-binding complex corresponded to Pdx-1, the ability of an antibody that recognizes Pdx-1 to supershift the A3 binding complex was tested. Addition of XIHbox8 antibodies to nuclear extracts isolated from AdCMV-βGAL-infected INS-1 cells supershifted the A3 binding complex ( Figure 5, lane 5) . These results clearly indicated that the reduction in Pdx-1 protein levels caused by USF2∆B overexpression led to a reduction in Pdx-1 binding to the A3 element contained in the insulin promoter.
A reduction in Pdx-1 binding activity to the insulin A3 element would be predicted to cause a reduction in insulin gene expression. This prediction was tested by measuring insulin mRNA levels by Northern-blot analysis. As shown in Figure 6 , AdCMV-USF2∆B-treated cells displayed a transient reduction in insulin mRNA levels. Thus 48 h after infection with AdCMV-USF2∆B, insulin mRNA levels were reduced to 46p9.9 % (n l 4, P 0.005) of that observed for control cells (Figure 6, lane 1 versus  lane 3) . No reductions in insulin mRNA levels were observed 72 h after treatment of INS-1 cells with AdCMV-USF2∆B. From these data we conclude that the " 55 % reduction in Pdx-1 binding activity to the A3 element of the insulin promoter was sufficient to transiently reduce insulin gene transcription. These data are also consistent with the hypothesis that USF functionally regulates Pdx-1 gene transcription.
DISCUSSION
The critical observation of this study is that overexpression of the dominant-negative USF2 protein, USF2∆B, reduces Pdx-1 gene promoter activity. A commensurate reduction in both Pdx-1 mRNA and Pdx-1 protein levels indicates that this change in reporter gene activity detected in a transient transfection assay actually reflected a change in expression of the endogenous Pdx-1 gene. Thus we conclude that USF plays a functional role in supporting the transcription of the Pdx-1 gene in the pancreatic β-cell. Two lines of evidence had previously suggested a role of USF in supporting Pdx-1 promoter activity [19] . First, mutation of a consensus binding site for USF at k107\k102 was shown to markedly decrease Pdx-1 promoter activity in transient transfection experiments. Secondly, USF present in nuclear extracts was shown to bind in itro to the Pdx-1 E box at k107\k102. Similar lines of evidence have been used as an argument for a role for USF in transcriptional activation of a large number of cellular genes. However, given the numerous basic\helix-loop-helix\leucine zipper factors capable of binding to the CACGTG motif recognized by USF, the nature of the actual factor recognizing the E box of the Pdx-1 (or other cellular genes) in i o has remained unclear. The USF2∆B form has previously been used to demonstrate a role for USF in supporting the transcription of a bi-directional herpes viral promoter [29] and fatty acid synthase reporter genes [53] . To our knowledge, the present study is the first to demonstrate directly that USF functionally regulates the expression of an endogenous gene encoding a normal cellular protein.
Although it was one of the earliest promoter-specific factors identified, the role of USF as a transcriptional activator has not been well established. Studies using a crude, reconstituted, cellfree system demonstrated that recombinant USF1 could stimulate transcriptional activity from the adenoviral major late promoter and HIV promoters in an E-box dependent manner [54, 55] . In co-transfection experiments, ecotopic expression of USF1 generally has been found to provide only modest stimulation of promoters containing USF binding E-box sites [55] [56] [57] . In other cases, ecotopic expression of USF led to significant reductions in promoter activities, perhaps due to displacement of other E-box-binding proteins with stronger activation domains [58] . The most dramatic activities of USF have been detected in situations in which USF acts synergistically with transcription factors from distinct families to stimulate transcription [29, 59] . In the case of the Pdx-1 gene, it is unclear, as yet, whether the actions of USF are mediated in synergy with another factor interacting with the Pdx-1 promoter sequences.
USF2∆B overexpression resulted in similar levels of reduction in both the k6500 bp and k190 bp promoter constructs, suggesting that USF2∆B lessens Pdx-1 gene promoter activity through a USF regulatory site(s) located within the k190 bp promoter. Attempts were made to determine whether USF2∆B was inhibiting Pdx-1 gene promoter activity through interference with the k107\k102 E-box motif. Mutation of the k107\k102 E-box motif reduced the ability of USF2∆B overexpression to inhibit Pdx-1 gene promoter activity suggesting that USF2∆B, in Regulation of Pdx-1 gene expression by upstream stimulatory factor part, is decreasing Pdx-1 gene promoter activity by interfering with binding at the k107\k102 E box. However, a decrease in Pdx-1 gene promoter activity still occurred in constructs containing mutation of the k107\k102 E box. Thus USF appears to act at sites other than just the k107\k102 E box. The effects of USF have also been found to occur through initiator elements rather than through classic E boxes in the HIV genome [55] . Although the presence of initiator elements in the Pdx-1 gene have not been demonstrated, the lack of a TATA box motif would be consistent with a role for initiator element(s) in promoting transcriptional initiation. Whatever the site(s) of USF action, the ability of USF2 expression to reverse the inhibitory effect of USF2∆B on Pdx-1 gene promoter activity supports the conclusion that USF2∆B overexpression is reducing Pdx-1 gene promoter activity by directly interfering with USF.
During the course of these studies, the effect of overexpression of USF2∆B on the regulation of the -pyruvate kinase promoter by glucose was also investigated. USF has been shown to bind to the carbohydrate-responsive element of the -pyruvate kinase promoter in itro [49, 60] , but whether USF plays a role in mediating glucose-induced changes in pyruvate kinase promoter activity remains controversial [31, 34] . As was observed for the Pdx-1 promoter E box, overexpression of USF2∆B led to a decrease in USF binding to the pyruvate kinase E-box sequences (k165\k149) contained within the carbohydrate-responsive element (J. Qian, E. N. Kaytor, H. C. Towle and L. K. Olson, unpublished work). Interestingly, overexpression of USF2∆B had no effect on basal or carbohydrate-induced expression of a carbohydrate-responsive -pyruvate kinase reporter gene in primary hepatocytes [34] or in INS-1 cells (J. Qian, E. N. Kaytor, H. C. Towle and L. K. Olson, unpublished work). The contrasting effect of overexpression of USF2∆B on the Pdx-1 gene promoter versus the -pyruvate kinase promoter supports the concept that not all E-box elements that serve as USF binding sites are functionally regulated by USF.
The decrease in Pdx-1 gene expression by overexpression of USF2∆B coincided with a transient reduction in insulin mRNA levels. The transient nature for the reduction in insulin gene expression is most likely due to the recovery of Pdx-1 expression that is observed 72 h after treatment with AdCMV-USF2∆B. In a recent study, Ahlgren et al. [18] reported that the loss of Pdx-1 protein in conditional knockout mice resulted in a marked reduction in both insulin and GLUT2 protein levels. In a similar manner, we also observed that a decrease in Pdx-1 protein by overexpression of USF2∆B reduced GLUT2 levels (results not shown). The decrease in insulin gene expression by overexpression of USF2∆B most likely results from the " 55 % reduction in Pdx-1 binding activity. The possibility that overexpression of USF2∆B is having a direct effect on insulin promoter activity, however, cannot be excluded. Indeed, Read et al. [61] and Cordle et al. [62] have reported that USF binds both the human insulin gene E2 and the rat insulin II E1 elements respectively. It is unlikely, however, that the decrease in insulin gene expression is due to displacement of USF from the insulin E-box elements, because only minimal amounts of USF bind to the rat insulin Ebox elements [62] .
In the light of our results, disruption of the USF genes within mice would be predicted to cause marked alterations in pancreatic development and β-cell phenotype. Recent studies by Vallet et al. [63, 64] and Sirito et al. [65] characterized both USF2 k\k and USF1 k\k mutant mice. No alterations in development or reproduction and no metabolic disorders were observed in USF1 k\k mutant mice [64, 65] . In contrast, USF2 k\k mutant mice displayed a growth defect at birth that was maintained throughout postnatal development [65] . In addition, the USF2 k\k mutant mice had decreased viability, lifespan and fertility, and had brain alterations that led to epileptic seizures [65] . As with the USF1 k\k mutant mice, USF2 k\k mutant mice displayed no metabolic disorders [63] . Importantly, embryonic lethality was observed in double USF2 k\k and USF1 k\k mutant mice [64, 65] , implying that USF is necessary for embryonic development. This also indicates that USF1 or USF2 homodimers are sufficient for the development and maintenance of viable animals. It is likely that overexpression of USF2∆B in INS-1 cells displaces both USF2\USF1 heterodimers and USF1\ USF1 and USF2\USF2 homodimers. Thus overexpression of USF2∆B most likely models the double USF2 k\k and USF1k\k mutant mice. Because double USF2 k\k and USF1 k\k mutant mice display embryonic lethality, no direct comparison with our studies is possible. In conclusion, our experimental results strongly support a functional role for USF in the regulation of Pdx-1 gene expression in differentiated pancreatic β-cells.
